Scenarios that move HROW

Harrow, Inc. - Common Stock

Scenarios that move HROW: 1 analysis, 0 positive, 1 negative.

  1. · Opus Genetics receives FDA approval for presbyopia eye drop — ▼ · impact -15 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing